Management of inflammatory breast cancer after neoadjuvant chemotherapy.
Identifieur interne : 003B18 ( Ncbi/Checkpoint ); précédent : 003B17; suivant : 003B19Management of inflammatory breast cancer after neoadjuvant chemotherapy.
Auteurs : Soumya Abrous-Anane [France] ; Alexia Savignoni ; Caroline Daveau ; Jean-Yves Pierga ; Chantal Gautier ; Fabien Reyal ; Remi Dendale ; François Campana ; Youlia M. Kirova ; Alain Fourquet ; Marc A. BolletSource :
- International journal of radiation oncology, biology, physics [ 1879-355X ] ; 2011.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Analyse de variance, Calendrier d'administration des médicaments, Cancers du sein inflammatoires (), Cancers du sein inflammatoires (anatomopathologie), Cancers du sein inflammatoires (radiothérapie), Cancers du sein inflammatoires (traitement médicamenteux), Cyclophosphamide (administration et posologie), Femelle, Fluorouracil (administration et posologie), Humains, Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Récidive tumorale locale (), Récidive tumorale locale (anatomopathologie), Stade de la tumeur, Sujet âgé, Survie sans rechute, Taux de survie, Traitement néoadjuvant (), Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (radiothérapie), Tumeurs du sein (traitement médicamenteux), Vinblastine (administration et posologie), Vinblastine (analogues et dérivés), Vindésine (administration et posologie), Études de suivi, Études rétrospectives.
- MESH :
- administration et posologie : Cyclophosphamide, Fluorouracil, Vinblastine, Vindésine.
- analogues et dérivés : Vinblastine.
- anatomopathologie : Cancers du sein inflammatoires, Récidive tumorale locale, Tumeurs du sein.
- radiothérapie : Cancers du sein inflammatoires, Tumeurs du sein.
- traitement médicamenteux : Cancers du sein inflammatoires, Tumeurs du sein.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- Adulte, Adulte d'âge moyen, Analyse de variance, Calendrier d'administration des médicaments, Cancers du sein inflammatoires, Femelle, Humains, Récidive tumorale locale, Stade de la tumeur, Sujet âgé, Survie sans rechute, Taux de survie, Traitement néoadjuvant, Tumeurs du sein, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Analysis of Variance, Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Breast Neoplasms (drug therapy), Breast Neoplasms (pathology), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Cyclophosphamide (administration & dosage), Disease-Free Survival, Drug Administration Schedule, Female, Fluorouracil (administration & dosage), Follow-Up Studies, Humans, Inflammatory Breast Neoplasms (drug therapy), Inflammatory Breast Neoplasms (pathology), Inflammatory Breast Neoplasms (radiotherapy), Inflammatory Breast Neoplasms (surgery), Middle Aged, Neoadjuvant Therapy (methods), Neoplasm Recurrence, Local (pathology), Neoplasm Recurrence, Local (surgery), Neoplasm Staging, Retrospective Studies, Survival Rate, Vinblastine (administration & dosage), Vinblastine (analogs & derivatives), Vindesine (administration & dosage).
- MESH :
- chemical , administration & dosage : Cyclophosphamide, Fluorouracil, Vinblastine, Vindesine.
- chemical , analogs & derivatives : Vinblastine.
- drug therapy : Breast Neoplasms, Inflammatory Breast Neoplasms.
- methods : Neoadjuvant Therapy.
- pathology : Breast Neoplasms, Inflammatory Breast Neoplasms, Neoplasm Recurrence, Local.
- radiotherapy : Breast Neoplasms, Inflammatory Breast Neoplasms.
- surgery : Breast Neoplasms, Inflammatory Breast Neoplasms, Neoplasm Recurrence, Local.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- Adult, Aged, Analysis of Variance, Disease-Free Survival, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Staging, Retrospective Studies, Survival Rate.
Abstract
To assess the benefit of breast surgery for inflammatory breast cancer (IBC).
DOI: 10.1016/j.ijrobp.2009.12.009
PubMed: 20478662
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002A70
- to stream PubMed, to step Curation: 002A70
- to stream PubMed, to step Checkpoint: 002A70
- to stream Ncbi, to step Merge: 003B18
- to stream Ncbi, to step Curation: 003B18
Links to Exploration step
pubmed:20478662Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of inflammatory breast cancer after neoadjuvant chemotherapy.</title>
<author><name sortKey="Abrous Anane, Soumya" sort="Abrous Anane, Soumya" uniqKey="Abrous Anane S" first="Soumya" last="Abrous-Anane">Soumya Abrous-Anane</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Radiation Oncology, Institut Curie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiation Oncology, Institut Curie, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Savignoni, Alexia" sort="Savignoni, Alexia" uniqKey="Savignoni A" first="Alexia" last="Savignoni">Alexia Savignoni</name>
</author>
<author><name sortKey="Daveau, Caroline" sort="Daveau, Caroline" uniqKey="Daveau C" first="Caroline" last="Daveau">Caroline Daveau</name>
</author>
<author><name sortKey="Pierga, Jean Yves" sort="Pierga, Jean Yves" uniqKey="Pierga J" first="Jean-Yves" last="Pierga">Jean-Yves Pierga</name>
</author>
<author><name sortKey="Gautier, Chantal" sort="Gautier, Chantal" uniqKey="Gautier C" first="Chantal" last="Gautier">Chantal Gautier</name>
</author>
<author><name sortKey="Reyal, Fabien" sort="Reyal, Fabien" uniqKey="Reyal F" first="Fabien" last="Reyal">Fabien Reyal</name>
</author>
<author><name sortKey="Dendale, Remi" sort="Dendale, Remi" uniqKey="Dendale R" first="Remi" last="Dendale">Remi Dendale</name>
</author>
<author><name sortKey="Campana, Francois" sort="Campana, Francois" uniqKey="Campana F" first="François" last="Campana">François Campana</name>
</author>
<author><name sortKey="Kirova, Youlia M" sort="Kirova, Youlia M" uniqKey="Kirova Y" first="Youlia M" last="Kirova">Youlia M. Kirova</name>
</author>
<author><name sortKey="Fourquet, Alain" sort="Fourquet, Alain" uniqKey="Fourquet A" first="Alain" last="Fourquet">Alain Fourquet</name>
</author>
<author><name sortKey="Bollet, Marc A" sort="Bollet, Marc A" uniqKey="Bollet M" first="Marc A" last="Bollet">Marc A. Bollet</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:20478662</idno>
<idno type="pmid">20478662</idno>
<idno type="doi">10.1016/j.ijrobp.2009.12.009</idno>
<idno type="wicri:Area/PubMed/Corpus">002A70</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002A70</idno>
<idno type="wicri:Area/PubMed/Curation">002A70</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A70</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A70</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A70</idno>
<idno type="wicri:Area/Ncbi/Merge">003B18</idno>
<idno type="wicri:Area/Ncbi/Curation">003B18</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003B18</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Management of inflammatory breast cancer after neoadjuvant chemotherapy.</title>
<author><name sortKey="Abrous Anane, Soumya" sort="Abrous Anane, Soumya" uniqKey="Abrous Anane S" first="Soumya" last="Abrous-Anane">Soumya Abrous-Anane</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Radiation Oncology, Institut Curie, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiation Oncology, Institut Curie, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Savignoni, Alexia" sort="Savignoni, Alexia" uniqKey="Savignoni A" first="Alexia" last="Savignoni">Alexia Savignoni</name>
</author>
<author><name sortKey="Daveau, Caroline" sort="Daveau, Caroline" uniqKey="Daveau C" first="Caroline" last="Daveau">Caroline Daveau</name>
</author>
<author><name sortKey="Pierga, Jean Yves" sort="Pierga, Jean Yves" uniqKey="Pierga J" first="Jean-Yves" last="Pierga">Jean-Yves Pierga</name>
</author>
<author><name sortKey="Gautier, Chantal" sort="Gautier, Chantal" uniqKey="Gautier C" first="Chantal" last="Gautier">Chantal Gautier</name>
</author>
<author><name sortKey="Reyal, Fabien" sort="Reyal, Fabien" uniqKey="Reyal F" first="Fabien" last="Reyal">Fabien Reyal</name>
</author>
<author><name sortKey="Dendale, Remi" sort="Dendale, Remi" uniqKey="Dendale R" first="Remi" last="Dendale">Remi Dendale</name>
</author>
<author><name sortKey="Campana, Francois" sort="Campana, Francois" uniqKey="Campana F" first="François" last="Campana">François Campana</name>
</author>
<author><name sortKey="Kirova, Youlia M" sort="Kirova, Youlia M" uniqKey="Kirova Y" first="Youlia M" last="Kirova">Youlia M. Kirova</name>
</author>
<author><name sortKey="Fourquet, Alain" sort="Fourquet, Alain" uniqKey="Fourquet A" first="Alain" last="Fourquet">Alain Fourquet</name>
</author>
<author><name sortKey="Bollet, Marc A" sort="Bollet, Marc A" uniqKey="Bollet M" first="Marc A" last="Bollet">Marc A. Bollet</name>
</author>
</analytic>
<series><title level="j">International journal of radiation oncology, biology, physics</title>
<idno type="eISSN">1879-355X</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Cyclophosphamide (administration & dosage)</term>
<term>Disease-Free Survival</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Fluorouracil (administration & dosage)</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Inflammatory Breast Neoplasms (drug therapy)</term>
<term>Inflammatory Breast Neoplasms (pathology)</term>
<term>Inflammatory Breast Neoplasms (radiotherapy)</term>
<term>Inflammatory Breast Neoplasms (surgery)</term>
<term>Middle Aged</term>
<term>Neoadjuvant Therapy (methods)</term>
<term>Neoplasm Recurrence, Local (pathology)</term>
<term>Neoplasm Recurrence, Local (surgery)</term>
<term>Neoplasm Staging</term>
<term>Retrospective Studies</term>
<term>Survival Rate</term>
<term>Vinblastine (administration & dosage)</term>
<term>Vinblastine (analogs & derivatives)</term>
<term>Vindesine (administration & dosage)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de variance</term>
<term>Calendrier d'administration des médicaments</term>
<term>Cancers du sein inflammatoires ()</term>
<term>Cancers du sein inflammatoires (anatomopathologie)</term>
<term>Cancers du sein inflammatoires (radiothérapie)</term>
<term>Cancers du sein inflammatoires (traitement médicamenteux)</term>
<term>Cyclophosphamide (administration et posologie)</term>
<term>Femelle</term>
<term>Fluorouracil (administration et posologie)</term>
<term>Humains</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Récidive tumorale locale ()</term>
<term>Récidive tumorale locale (anatomopathologie)</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Survie sans rechute</term>
<term>Taux de survie</term>
<term>Traitement néoadjuvant ()</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
<term>Vinblastine (administration et posologie)</term>
<term>Vinblastine (analogues et dérivés)</term>
<term>Vindésine (administration et posologie)</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cyclophosphamide</term>
<term>Fluorouracil</term>
<term>Vinblastine</term>
<term>Vindesine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Vinblastine</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cyclophosphamide</term>
<term>Fluorouracil</term>
<term>Vinblastine</term>
<term>Vindésine</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Vinblastine</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Cancers du sein inflammatoires</term>
<term>Récidive tumorale locale</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Inflammatory Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Neoadjuvant Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Inflammatory Breast Neoplasms</term>
<term>Neoplasm Recurrence, Local</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Inflammatory Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Cancers du sein inflammatoires</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
<term>Inflammatory Breast Neoplasms</term>
<term>Neoplasm Recurrence, Local</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Cancers du sein inflammatoires</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Disease-Free Survival</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Retrospective Studies</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de variance</term>
<term>Calendrier d'administration des médicaments</term>
<term>Cancers du sein inflammatoires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Récidive tumorale locale</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Survie sans rechute</term>
<term>Taux de survie</term>
<term>Traitement néoadjuvant</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To assess the benefit of breast surgery for inflammatory breast cancer (IBC).</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Bollet, Marc A" sort="Bollet, Marc A" uniqKey="Bollet M" first="Marc A" last="Bollet">Marc A. Bollet</name>
<name sortKey="Campana, Francois" sort="Campana, Francois" uniqKey="Campana F" first="François" last="Campana">François Campana</name>
<name sortKey="Daveau, Caroline" sort="Daveau, Caroline" uniqKey="Daveau C" first="Caroline" last="Daveau">Caroline Daveau</name>
<name sortKey="Dendale, Remi" sort="Dendale, Remi" uniqKey="Dendale R" first="Remi" last="Dendale">Remi Dendale</name>
<name sortKey="Fourquet, Alain" sort="Fourquet, Alain" uniqKey="Fourquet A" first="Alain" last="Fourquet">Alain Fourquet</name>
<name sortKey="Gautier, Chantal" sort="Gautier, Chantal" uniqKey="Gautier C" first="Chantal" last="Gautier">Chantal Gautier</name>
<name sortKey="Kirova, Youlia M" sort="Kirova, Youlia M" uniqKey="Kirova Y" first="Youlia M" last="Kirova">Youlia M. Kirova</name>
<name sortKey="Pierga, Jean Yves" sort="Pierga, Jean Yves" uniqKey="Pierga J" first="Jean-Yves" last="Pierga">Jean-Yves Pierga</name>
<name sortKey="Reyal, Fabien" sort="Reyal, Fabien" uniqKey="Reyal F" first="Fabien" last="Reyal">Fabien Reyal</name>
<name sortKey="Savignoni, Alexia" sort="Savignoni, Alexia" uniqKey="Savignoni A" first="Alexia" last="Savignoni">Alexia Savignoni</name>
</noCountry>
<country name="France"><region name="Île-de-France"><name sortKey="Abrous Anane, Soumya" sort="Abrous Anane, Soumya" uniqKey="Abrous Anane S" first="Soumya" last="Abrous-Anane">Soumya Abrous-Anane</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 003B18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:20478662 |texte= Management of inflammatory breast cancer after neoadjuvant chemotherapy. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:20478662" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |